Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Researchers suggest that MultiCell could potentially be used to discern early patterns of disease, such as in asthma.

Liver cells exposed to a high fat diet revert to an immature state that is more susceptible to cancer-causing mutations.

Samsung Biologics will acquire the Rockville assets for $280 million with closing anticipated toward the end of Q1 of 2026.

Data from a disease model showed that HSV1 infection caused tau hyperphosphorylation, forming aggregates that trapped viral ...

GEN lists the top five performing biotech stocks of 2025 and the five biotech stocks that fell the most during this past year, with brief explanations for the increases or declines.

Study demonstrated that the Homer1 gene improves focus by reducing “noise” in the prefrontal cortex, with implications for studying attention disorders.

The documents in this eBook provide a glimpse of the kinds of questions asked and answered by researchers using the SomaScan Platform unmatched breakthrough technology.

A new study shows how histones undergo correct chemical modifications during synthesis to guide new therapies.

In this GEN webinar, DNA synthesis experts Michael Junkin, PhD, and Brittany Enzmann, PhD, will provide an exclusive first look at Elegen’s GEN II Cell-Free DNA production platform that combines ...

This rapid screening process identified an iridium-based antibiotic candidate that shows promise in human cells to kill bacteria while remaining nontoxic.

New findings could aid future development of more efficient therapeutic strategies in the context of regenerative medicine and aging.